Tamara Joseph

Ms. Tamara Joseph is the Chief Legal Officer at Spero Therapeutics. She is a seasoned health care leader, having served on executive teams and advised Boards of Directors at multiple publicly and privately-held companies. She has led legal, compliance, human resources, public and government affairs, and risk management departments at life science companies in the US and in Europe for over 20 years. Prior to joining Spero in December 2020, she served as General Counsel at Millendo Therapeutics, Inc. Ms. Joseph previously served as General Counsel at Enzyvant Therapeutics Ltd., InVivo Therapeutics Holdings Corp., Cubist Pharmaceuticals, Inc., Mayne Pharma Ltd. (acquired by Hospira), and Transkaryotic Therapies, Inc. (acquired by Shire). Earlier in her career, Ms. Joseph established and led Biogen Idec’s legal and public affairs departments outside the US. She began her legal career at the law firms of Morrison & Foerster and Fried Frank. She has a BA in Economics from Duke University, a JD from the University of Michigan Law School, and LLM degrees from the College of Europe in Belgium and the University of Paris.Ms. Joseph is also a member of the Board of Directors of Heluna Health, a member of the Board’s Executive Committee and its Governance Committee. Heluna Health is a population health non-profit with a focus on child and maternal nutrition, HIV prevention and homelessness. Ms. Joseph is also an independent director on the Board of BINA Farm Center, a therapeutic horseback riding association.